Get started
Author

Tarık Onur Tiryaki

Observed names: Onur Tarık Tiryaki, T. O. Tiryaki, T. Tiryaki, Tarik Onur Tiryaki, Tarik Tiryaki, Tarık Onur TIRYAKI, Tarık Onur TİRYAKİ, Tiryaki, Tarik Onur, Tiryaki, Tarık Onur, TİRYAKİ, TARIK ONUR
Observed institutions: St. Jude Children's Research Hospital, University of Zagreb, Ege University, University Clinical Center of Kosovo, Institutul Oncologic din Republica Moldova, Istanbul University-Cerrahpaşa, Medical University of Lodz, Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi, Izmir Bozyaka Eğitim ve Araştırma Hastanesi, Hôpital Saint-Louis, Şişli Etfal Eğitim ve Araştırma Hastanesi, Saitama Medical Center, Saitama Medical University, Istanbul University
ORCID: 0000-0002-0096-5684
Observed ORCID: 0000-0002-0096-5684
OpenAlex ID: A5072883549
Immunosuppressive Treatment in C3 Glomerulopathy: Is it Really Effective?
2017 · Yasar Caliskan, Ege Sinan Torun, et al. · American Journal of Nephrology · 60
Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results
2021 · Serkan Kuyumcu, Emine Goknur Isik, et al. · Annals of Nuclear Medicine · 40
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand.
2020 · Vincenzo De Sanctis, Duran Canatan, et al. · Acta bio-medica dell'Ateneo parmense/Acta biomedica · 11
PDF
Comprehensive mastocytosis data analysis from a single center
2023 · Tarık Onur Tiryaki, Sıdıka Gülkan Özkan, et al. · BMC Cancer · 8
PDF
The Real‐World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
2021 · Seval Akpinar, Mehmet Hilmi Dogu, et al. · Clinical Lymphoma Myeloma & Leukemia · 8
Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma
2021 · Ipek Yonal-Hindilerden, Fehmi Hindilerden, et al. · Frontiers in Oncology · 7
PDF
Prolonged Severe Watery Diarrhea in a Long-Term Myeloma Survivor: An Unforeseen Infection with Cystoisospora belli
2020 · Tarık Onur Tiryaki, Kadir Uluç Anıl, et al. · Turkish Journal of Hematology · 7
PDF
Impaired endothelial function irrespective of systemic inflammation or atherosclerosis in mastocytosis
2021 · Nida Öztop, Pelin Karaca Özer, et al. · Annals of Allergy Asthma & Immunology · 6
PDF
A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
2020 · Mert Erciyestepe, Tarık Onur Tiryaki, et al. · Case Reports in Hematology · 6
PDF
Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
2020 · Onur Alkan, Tarik Onur Tiryaki, et al. · Journal of Medical Cases · 5
PDF
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias
2025 · Abdullah Karakus, Tayfur Toptas, et al. · Bone Marrow Transplantation · 3
PDF
Malnutrition treatment and follow-up in clinical nutrition outpatient clinics associated with increased muscle mass
2022 · Bulent Saka, Murat Bektas, et al. · Nutrition · 3
Budd-Chiari Syndrome: An Unusual Complication of AL amyloidosis
2020 · Onur Tarık Tiryaki, İpek Yonal Hindilerden, et al. · Turkish Journal of Hematology · 3
PDF
CalR and MPL Driver Mutations and Their Role in the Diagnosis and Clinical Course of JAK2-Unmutated Chronic Myeloproliferative Neoplasm: Results from a Pilot Single-Center Study
2025 · Tarık Onur Tiryaki, Aynur Dağlar-Aday, et al. · Medicina · 2
PDF
Efficacy of Ruxolitinib in the management of chronic GVHD
2024 · Asli Odabasi Giden, Mehmet Ali Erkurt, et al. · Transfusion and Apheresis Science · 2
PDF
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?
2024 · Turgay Ulas, Sinem Namdaroglu, et al. · Transfusion and Apheresis Science · 2
PDF
Baseline inflammation indexes and neutrophil‐to‐LDH ratio for prediction of the first mobilization failure without plerixafor‐based regimens in multiple myeloma and lymphoma patients: A single‐center retrospective study
2023 · Ahmet Burak Dirim, Tarik Onur Tiryaki, et al. · Journal of Clinical Apheresis · 2
PDF
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
2022 · Murat Özbalak, Metban Mastanzade, et al. · Turkish Journal of Hematology · 2
PDF
Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety
2025 · Mehmet Bakirtas, Ipek Yonal Hindilerden, et al. · Indian Journal of Hematology and Blood Transfusion · 1
PDF
The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes
2025 · Burcu Aslan Candir, Nazik Okumus, et al. · Transfusion and Apheresis Science · 1
Are mesenchymal stem cells still effective in acute GvHD management?
2024 · Bahar Uncu Ulu, Ipek Yonal Hindilerden, et al. · Transfusion and Apheresis Science · 1
PDF
CT-308 Primary Hemophagocytic Lymphohistiocytosis in an Adult Woman: Griscelli Syndrome Type 2 (Gs2) Without Hypopigmentation
2024 · Tuğba Usta, Tarık Onur Tiryaki, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
CT-313 Long-Term Remission After Nelarabine and Donor Lymphocyte Infusion in a Patient With T-ALL Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
2024 · Kıvanç Koruk, Tarık Onur Tiryaki, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
CT-312 Secondary Solid Tumor After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
2024 · Ulviyya Hasanzade, Kıvanç Koruk, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Concurrent Cobalamin C and Plasminogen Deficiencies in a Patient with Chronic Thrombotic Microangiopathy
2023 · Ahmet Burak Dirim, Seda Safak, et al. · The Nephron journals/Nephron journals · 1
Works count: 62
Citation count: 189
H-index: 7
I10-index: 3
Year
Topic
Type